Selected research
Market Structure
Global Cell Culture Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cell Culture Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cell Culture Service include Danaher, Lonza, WuXi Biologics, Samsung Biologics, Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, Evotec and Catalent, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cell Culture Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cell Culture Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cell Culture Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cell Culture Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Cell Culture Service Segment by Company
Danaher
Lonza
WuXi Biologics
Samsung Biologics
Charles River Laboratories
Labcorp Drug Development
Eurofins Scientific
Evotec
Catalent
AGC Biologics
ProBioGen
Pharmaron
Takara Bio
AGC Biologics Japan
Thermo Fisher Scientific
Merck KGaA
Sartorius
Cell Culture Service Segment by Type
Primary Cells
Transformed Cells
Self-renewing Cells
Cell Culture Service Segment by Application
Research Institute
Hospital
Others
Cell Culture Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Culture Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cell Culture Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cell Culture Service industry.
Chapter 3: Detailed analysis of Cell Culture Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Culture Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Primary Cells
- Transformed Cells
- Self-renewing Cells
Applications
- Research Institute
- Hospital
- Others
Companies covered
- Danaher
- Lonza
- WuXi Biologics
- Samsung Biologics
- Charles River Laboratories
- Labcorp Drug Development
- Eurofins Scientific
- Evotec
- Catalent
- AGC Biologics
- ProBioGen
- Pharmaron
- Takara Bio
- AGC Biologics Japan
- Thermo Fisher Scientific
- Merck KGaA
- Sartorius
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cell Culture Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Primary Cells
- 1.2.3 Transformed Cells
- 1.2.4 Self-renewing Cells
- 1.3 Market Analysis by Application
- 1.3.1 Global Cell Culture Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Research Institute
- 1.3.3 Hospital
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Cell Culture Service Growth Trends by Region
- 1.5.1 Global Cell Culture Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cell Culture Service Market Size by Region (2021-2026)
- 1.5.3 Cell Culture Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cell Culture Service Market Dynamics
- 2.1 Cell Culture Service Industry Trends
- 2.2 Cell Culture Service Industry Drivers
- 2.3 Cell Culture Service Industry Opportunities and Challenges
- 2.4 Cell Culture Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cell Culture Service Revenue by Company (2021-2026)
- 3.2 Global Cell Culture Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cell Culture Service Key Company Head office and Area Served
- 3.4 Global Cell Culture Service Company, Product Type & Application
- 3.5 Global Cell Culture Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cell Culture Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cell Culture Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Cell Culture Service Tier 1, Tier 2, and Tier 3
4 Cell Culture Service Market by Type
- 4.1 Global Cell Culture Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cell Culture Service Market Size by Type (2021-2032)
- 4.3 Global Cell Culture Service Market Size Share by Type (2021-2032)
5 Cell Culture Service Market by Application
- 5.1 Global Cell Culture Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cell Culture Service Market Size by Application (2021-2032)
- 5.3 Global Cell Culture Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Danaher
- 6.1.1 Danaher Company Information
- 6.1.2 Danaher Business Overview
- 6.1.3 Danaher Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Danaher Cell Culture Service Product Portfolio
- 6.1.5 Danaher Recent Developments
- 6.2 Lonza
- 6.2.1 Lonza Company Information
- 6.2.2 Lonza Business Overview
- 6.2.3 Lonza Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Lonza Cell Culture Service Product Portfolio
- 6.2.5 Lonza Recent Developments
- 6.3 WuXi Biologics
- 6.3.1 WuXi Biologics Company Information
- 6.3.2 WuXi Biologics Business Overview
- 6.3.3 WuXi Biologics Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 WuXi Biologics Cell Culture Service Product Portfolio
- 6.3.5 WuXi Biologics Recent Developments
- 6.4 Samsung Biologics
- 6.4.1 Samsung Biologics Company Information
- 6.4.2 Samsung Biologics Business Overview
- 6.4.3 Samsung Biologics Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Samsung Biologics Cell Culture Service Product Portfolio
- 6.4.5 Samsung Biologics Recent Developments
- 6.5 Charles River Laboratories
- 6.5.1 Charles River Laboratories Company Information
- 6.5.2 Charles River Laboratories Business Overview
- 6.5.3 Charles River Laboratories Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Charles River Laboratories Cell Culture Service Product Portfolio
- 6.5.5 Charles River Laboratories Recent Developments
- 6.6 Labcorp Drug Development
- 6.6.1 Labcorp Drug Development Company Information
- 6.6.2 Labcorp Drug Development Business Overview
- 6.6.3 Labcorp Drug Development Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Labcorp Drug Development Cell Culture Service Product Portfolio
- 6.6.5 Labcorp Drug Development Recent Developments
- 6.7 Eurofins Scientific
- 6.7.1 Eurofins Scientific Company Information
- 6.7.2 Eurofins Scientific Business Overview
- 6.7.3 Eurofins Scientific Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Eurofins Scientific Cell Culture Service Product Portfolio
- 6.7.5 Eurofins Scientific Recent Developments
- 6.8 Evotec
- 6.8.1 Evotec Company Information
- 6.8.2 Evotec Business Overview
- 6.8.3 Evotec Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Evotec Cell Culture Service Product Portfolio
- 6.8.5 Evotec Recent Developments
- 6.9 Catalent
- 6.9.1 Catalent Company Information
- 6.9.2 Catalent Business Overview
- 6.9.3 Catalent Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Catalent Cell Culture Service Product Portfolio
- 6.9.5 Catalent Recent Developments
- 6.10 AGC Biologics
- 6.10.1 AGC Biologics Company Information
- 6.10.2 AGC Biologics Business Overview
- 6.10.3 AGC Biologics Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 AGC Biologics Cell Culture Service Product Portfolio
- 6.10.5 AGC Biologics Recent Developments
- 6.11 ProBioGen
- 6.11.1 ProBioGen Company Information
- 6.11.2 ProBioGen Business Overview
- 6.11.3 ProBioGen Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 ProBioGen Cell Culture Service Product Portfolio
- 6.11.5 ProBioGen Recent Developments
- 6.12 Pharmaron
- 6.12.1 Pharmaron Company Information
- 6.12.2 Pharmaron Business Overview
- 6.12.3 Pharmaron Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Pharmaron Cell Culture Service Product Portfolio
- 6.12.5 Pharmaron Recent Developments
- 6.13 Takara Bio
- 6.13.1 Takara Bio Company Information
- 6.13.2 Takara Bio Business Overview
- 6.13.3 Takara Bio Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Takara Bio Cell Culture Service Product Portfolio
- 6.13.5 Takara Bio Recent Developments
- 6.14 AGC Biologics Japan
- 6.14.1 AGC Biologics Japan Company Information
- 6.14.2 AGC Biologics Japan Business Overview
- 6.14.3 AGC Biologics Japan Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 AGC Biologics Japan Cell Culture Service Product Portfolio
- 6.14.5 AGC Biologics Japan Recent Developments
- 6.15 Thermo Fisher Scientific
- 6.15.1 Thermo Fisher Scientific Company Information
- 6.15.2 Thermo Fisher Scientific Business Overview
- 6.15.3 Thermo Fisher Scientific Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Thermo Fisher Scientific Cell Culture Service Product Portfolio
- 6.15.5 Thermo Fisher Scientific Recent Developments
- 6.16 Merck KGaA
- 6.16.1 Merck KGaA Company Information
- 6.16.2 Merck KGaA Business Overview
- 6.16.3 Merck KGaA Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Merck KGaA Cell Culture Service Product Portfolio
- 6.16.5 Merck KGaA Recent Developments
- 6.17 Sartorius
- 6.17.1 Sartorius Company Information
- 6.17.2 Sartorius Business Overview
- 6.17.3 Sartorius Cell Culture Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Sartorius Cell Culture Service Product Portfolio
- 6.17.5 Sartorius Recent Developments
7 North America
- 7.1 North America Cell Culture Service Market Size (2021-2032)
- 7.2 North America Cell Culture Service Market Size by Type
- 7.2.1 North America Cell Culture Service Market Size by Type (2021-2026)
- 7.2.2 North America Cell Culture Service Market Size by Type (2027-2032)
- 7.2.3 North America Cell Culture Service Market Share by Type (2021-2032)
- 7.3 North America Cell Culture Service Market Size by Application
- 7.3.1 North America Cell Culture Service Market Size by Application (2021-2026)
- 7.3.2 North America Cell Culture Service Market Size by Application (2027-2032)
- 7.3.3 North America Cell Culture Service Market Share by Application (2021-2032)
- 7.4 North America Cell Culture Service Market Size by Country
- 7.4.1 North America Cell Culture Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cell Culture Service Market Size by Country (2021-2026)
- 7.4.3 North America Cell Culture Service Market Size by Country (2027-2032)
- 7.4.4 North America Cell Culture Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cell Culture Service Market Size (2021-2032)
- 8.2 Europe Cell Culture Service Market Size by Type
- 8.2.1 Europe Cell Culture Service Market Size by Type (2021-2026)
- 8.2.2 Europe Cell Culture Service Market Size by Type (2027-2032)
- 8.2.3 Europe Cell Culture Service Market Share by Type (2021-2032)
- 8.3 Europe Cell Culture Service Market Size by Application
- 8.3.1 Europe Cell Culture Service Market Size by Application (2021-2026)
- 8.3.2 Europe Cell Culture Service Market Size by Application (2027-2032)
- 8.3.3 Europe Cell Culture Service Market Share by Application (2021-2032)
- 8.4 Europe Cell Culture Service Market Size by Country
- 8.4.1 Europe Cell Culture Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cell Culture Service Market Size by Country (2021-2026)
- 8.4.3 Europe Cell Culture Service Market Size by Country (2027-2032)
- 8.4.4 Europe Cell Culture Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cell Culture Service Market Size (2021-2032)
- 9.2 China Cell Culture Service Market Size by Type
- 9.2.1 China Cell Culture Service Market Size by Type (2021-2026)
- 9.2.2 China Cell Culture Service Market Size by Type (2027-2032)
- 9.2.3 China Cell Culture Service Market Share by Type (2021-2032)
- 9.3 China Cell Culture Service Market Size by Application
- 9.3.1 China Cell Culture Service Market Size by Application (2021-2026)
- 9.3.2 China Cell Culture Service Market Size by Application (2027-2032)
- 9.3.3 China Cell Culture Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cell Culture Service Market Size (2021-2032)
- 10.2 Asia Cell Culture Service Market Size by Type
- 10.2.1 Asia Cell Culture Service Market Size by Type (2021-2026)
- 10.2.2 Asia Cell Culture Service Market Size by Type (2027-2032)
- 10.2.3 Asia Cell Culture Service Market Share by Type (2021-2032)
- 10.3 Asia Cell Culture Service Market Size by Application
- 10.3.1 Asia Cell Culture Service Market Size by Application (2021-2026)
- 10.3.2 Asia Cell Culture Service Market Size by Application (2027-2032)
- 10.3.3 Asia Cell Culture Service Market Share by Application (2021-2032)
- 10.4 Asia Cell Culture Service Market Size by Country
- 10.4.1 Asia Cell Culture Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cell Culture Service Market Size by Country (2021-2026)
- 10.4.3 Asia Cell Culture Service Market Size by Country (2027-2032)
- 10.4.4 Asia Cell Culture Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cell Culture Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cell Culture Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Cell Culture Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cell Culture Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cell Culture Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cell Culture Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Cell Culture Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cell Culture Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cell Culture Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cell Culture Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Cell Culture Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cell Culture Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cell Culture Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cell Culture Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst